L3Harris Technologies Inc (HRS BE) stock market data APIs
€251.1115
0(0%)
as of October 22, 2025
Try our APIs with
free plan!
L3Harris Technologies Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for HRS.BE.
Prev. Close
251.1115
Open
251.1115
High
251.1115
Low
251.1115
52 wk Range
174.3382-262.3
Market Cap
37 669 M
EPS
2.41
Dividends (Yield)
0.0128
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get L3Harris Technologies Inc data using free add-ons & libraries
Get L3Harris Technologies Inc Fundamental Data
L3Harris Technologies Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-24
- EPS/Forecast: 2.34
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
L3Harris Technologies Inc News
New
What Recent Contract Wins Mean for L3Harris Stock Valuation in 2025
If you are on the fence about L3Harris Technologies stock, you are not alone. The past year has been full of surprises for L3Harris, and its stock has given investors plenty of reasons to pay attentio...
ACHR Outperforms Industry Over the Past Month: Should You Buy the Stock?
Archer Aviation Inc.’s ACHR shares gained 25.5% in the past month, outperforming the Zacks Aerospace-Defense industry’s growth of 0.3% as well as the broader Zacks Aerospace sector’s gain of 0.7...
Northrop Grumman Q3 Earnings Top, Revenues Miss, '25 EPS View Raised
Northrop Grumman Corporation NOC reported third-quarter 2025 adjusted earnings of $7.67 per share, which beat the Zacks Consensus Estimate of $6.49 by 18.2%. The bottom line also increased 9.6% from $...
Company News for Oct 21, 2025
Summit Therapeutics Inc.’s SMMT shares slid 4.6% after reporting third-quarter 2025 losses of 31 cents per share, wider than the Zacks Consensus Estimate loss of 14 cents. Shares of Cleveland-Cliffs...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
